Observational Study With InnoLet® in Daily Clinical Practice

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT01059799 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes Mellitus

NCT01169818 ·Status: COMPLETED ·Phase: PHASE4

Observational Study of Patients With Diabetes Using Levemir® FlexPen®

NCT00670683 ·Status: COMPLETED

Observational Study of NovoNorm® in Subjects With Diabetes

NCT01498913 ·Status: COMPLETED

Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

NCT00806897 ·Status: COMPLETED

Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea

NCT00455858 ·Status: COMPLETED ·Phase: PHASE4

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes

NCT01849289 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on Safety of Self-titration of Once Daily Levemir®

NCT00740519 ·Status: COMPLETED

Trial Investigating the Safety of NNC 0113-0987 in Healthy Male Subjects

NCT01405261 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin

NCT03760991 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects

NCT02094521 ·Status: COMPLETED ·Phase: PHASE1

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

NCT01492166 ·Status: COMPLETED

Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus

NCT01326026 ·Status: COMPLETED ·Phase: PHASE3

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

NCT01203111 ·Status: COMPLETED ·Phase: PHASE4

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

NCT00687063 ·Status: COMPLETED

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

NCT00593255 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy

NCT02855684 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

NCT00737776 ·Status: COMPLETED

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy Subjects

NCT02479022 ·Status: COMPLETED ·Phase: PHASE1

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01226966 ·Status: COMPLETED

Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes

NCT00712478 ·Status: COMPLETED

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

NCT00859079 ·Status: COMPLETED ·Phase: PHASE4

Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

NCT04932928 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

NCT00290979 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus

NCT01175811 ·Status: COMPLETED ·Phase: PHASE4